Entrada Therapeutics, Inc. - TRDA

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$338.6M

QoQ value delta ($000)

+$87.37M (+34.78%)

Implied price effect (QoQ)

+21.44%

Total shares

27,148,469

QoQ shares delta

+2,687,153 (+10.99%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 119 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
BAKER BROS. ADVISORS LP	64,017	5,072,730	0.37%
5AM Venture Management, LLC	51,191	4,056,379	14.21%
BlackRock, Inc.	29,767	2,358,793	0.0%
TCG Crossover Management, LLC	28,868	2,287,500	0.83%
VANGUARD GROUP INC	16,781	1,632,460	0.0%
VANGUARD CAPITAL MANAGEMENT LLC	15,850	1,256,013	0.0%
WELLINGTON MANAGEMENT GROUP LLP	13,058	1,034,782	0.0%
StepStone Group LP	9,607	761,277	4.63%
GEODE CAPITAL MANAGEMENT, LLC	8,423	667,347	0.0%
STATE STREET CORP	6,736	533,798	0.0%
PRICE T ROWE ASSOCIATES INC /MD/	6,639	526,043	0.0%
MILLENNIUM MANAGEMENT LLC	6,554	519,356	0.0%
Jones Hill Capital LP	4,720	374,010	1.01%
JACOBS LEVY EQUITY MANAGEMENT, INC	4,213	333,914	0.02%
ACADIAN ASSET MANAGEMENT LLC	4,201	333,169	0.01%
DIMENSIONAL FUND ADVISORS LP	4,091	324,471	0.0%
NORTHERN TRUST CORP	2,965	234,992	0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC	2,782	220,494	0.0%
Woodline Partners LP	2,725	215,977	0.01%
CITADEL ADVISORS LLC	2,713	215,018	0.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	2,710	214,751	0.0%
GOLDMAN SACHS GROUP INC	2,685	212,780	0.0%
Lynx1 Capital Management LP	2,671	211,689	0.42%
Longaeva Partners L.P.	2,586	204,978	0.1%
RENAISSANCE TECHNOLOGIES LLC	2,550	202,084	0.0%